BellaSeno GmbH
About BellaSeno GmbH
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Grant T: - FT: Grant |
A: 415500000 MR: - FA: $415.5 million FAN: 415500000 |
D: 2024-06-05 FD: 2024-06-05 |
1 investors |
Growth Metrics
Team & Leadership
Dr. Mohit P. Chhaya
Chief Executive Officer (CEO) / Co-Founder
Dr. med. Tobias Grossner
Chief Medical Officer (CMO)
Dr. Thomas Lingner
Chief Technology Officer
Sanat Dimetriou-Dickson
Chief Marketing Officer
Herbert Stadler, PhD
Chairman Supervisory Board / Series A+B Investor
Dr. Mark L. Jewell
Clinical Advisor
Recent News
BellaSeno GmbH Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- bellaseno.com
- Industries
- Medical Device / Regenerative Medicine
- Company Size
- ~620 employees (est.)
- Locations
-
Leipzig, Germany / Brisbane, Australia
Leipzig, Germany and Brisbane, Australia
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro